<?xml version="1.0" encoding="UTF-8"?>
<p id="P20">Famciclovir is active against HSV-1, HSV-2, and VZV, and, to a lesser extent, against EBV. Its mechanism of action is through penciclovir; penciclovir triphosphate inhibits herpes DNA synthesis by acting as a substrate for viral DNA polymerase. The major clinical indications for famciclovir use are treatment of herpes zoster, recurrent genital herpes,
 <sup>
  <xref ref-type="bibr" rid="R52">52</xref>
 </sup> and recurrent herpes labialis.
 <sup>
  <xref ref-type="bibr" rid="R53">53</xref>
 </sup> Famciclovir can also be used as suppression therapy to reduce the risk of recurrent genital herpes as well as oral treatment of uncomplicated varicella in HIV-infected patients.
</p>
